Author Interviews, Biomarkers, Cancer Research, Hepatitis - Liver Disease / 18.05.2022
Liver Cancer: UT Southwestern Researchers Identify Blood Marker for Elevated Risk
MedicalResearch.com Interview with:
Yujin Hoshida, MD, PhD
Director, Liver Tumor Translational Research Program
CPRIT Scholar in Cancer Research
Harold C. Simmons Comprehensive Cancer Center
Professor of Internal Medicine
Division of Digestive and Liver Diseases, Department of Internal Medicine
University of Texas Southwestern Medical Center
MedicalResearch.com: What is the background for this study?
Response: Liver cancer is the fastest rising cause of cancer-related death in the U.S. with the sharply growing epidemic of obesity and non-alcoholic fatty liver disease. Late diagnosis at advanced stage is the main reason for the poor survival of liver cancer patients. Therefore, professional societies recommend semi-annual liver cancer screening for early diagnosis. However, it's practically infeasible due to the vast size of patient population (estimated to affect one-fourth of population).
Thus, we urgently need tools to identify a small subset of patients with elevated liver cancer risk, on which we can concentrate our effort of screening.
(more…)